Search hospitals > South Carolina > Myrtle Beach
Carolina Urologic Research Center
Claim this profileMyrtle Beach, South Carolina 29572
Global Leader in Prostate Cancer
Global Leader in Bladder Cancer
Conducts research for Transitional Cell Carcinoma
Conducts research for Cancer
Conducts research for Vulval Intraepithelial Neoplasia
158 reported clinical trials
3 medical researchers
Summary
Carolina Urologic Research Center is a medical facility located in Myrtle Beach, South Carolina. This center is recognized for care of Prostate Cancer, Bladder Cancer, Transitional Cell Carcinoma, Cancer, Vulval Intraepithelial Neoplasia and other specialties. Carolina Urologic Research Center is involved with conducting 158 clinical trials across 99 conditions. There are 3 research doctors associated with this hospital, such as Neal Shore, Abhishek Srivastava, MD, and Robert Jansen, MD.Area of expertise
1Prostate Cancer
Global LeaderStage IV
Stage I
Stage II
2Bladder Cancer
Global LeaderStage IV
Stage III
FGFR3 positive
Top PIs
Neal ShoreCarolina Urologic Research Center5 years of reported clinical research
Expert in Prostate Cancer
Expert in Bladder Cancer
36 reported clinical trials
53 drugs studied
Abhishek Srivastava, MDCarolina Urologic Research Center1 year of reported clinical research
Studies Bladder Cancer
Studies Transitional Cell Carcinoma
2 reported clinical trials
2 drugs studied
Robert Jansen, MDCarolina Urologic Research Center3 years of reported clinical research
Studies Prostate Cancer
1 reported clinical trial
2 drugs studied
Clinical Trials running at Carolina Urologic Research Center
Prostate Cancer
Bladder Cancer
Kidney Cancer
Ovarian Cancer
Lung Cancer
Cervical Adenocarcinoma
Transitional Cell Carcinoma
Relapse
Squamous Cell Carcinoma
Ureter Cancer
Lutetium (177Lu) Vipivotide Tetraxetan
for Prostate Cancer
The purpose of this study is to evaluate the efficacy and safety of lutetium (177Lu) vipivotide tetraxetan (AAA617) in participants with oligometastatic prostate cancer (OMPC) progressing after definitive therapy to their primary tumor. The data generated from this study will provide evidence for the treatment of AAA617 in early-stage prostate cancer patients to control recurrent tumor from progressing to fatal metastatic disease while preserving quality of life by delaying treatment with androgen deprivation therapy (ADT).
Recruiting2 awards Phase 36 criteria
64Cu-SAR-bisPSMA PET Scan
for Prostate Cancer
The aim for this study is to assess the diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases.
Recruiting2 awards Phase 35 criteria
AAA817 + ARPI
for Prostate Cancer
The purpose of this study is to determine whether \[225Ac\]Ac-PSMA-617 (AAA817), given for up to 6 cycles at a dose of 10 Megabecquerel (MBq) +/- 10%, plus androgen receptor pathway inhibitor (ARPI), improves the radiographic progression free survival (rPFS) compared to investigator's choice of standard of care (SOC) (ARPI change or taxane-based chemotherapy) in adult participants with PSMA-positive metastatic castration resistant prostate cancer (mCRPC) treated with another ARPI as last treatment and who have not been exposed to a taxane-containing chemotherapy in the mCRPC setting nor have received any prior PSMA-targeting radioligand therapy.
Recruiting2 awards Phase 37 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Carolina Urologic Research Center?
Carolina Urologic Research Center is a medical facility located in Myrtle Beach, South Carolina. This center is recognized for care of Prostate Cancer, Bladder Cancer, Transitional Cell Carcinoma, Cancer, Vulval Intraepithelial Neoplasia and other specialties. Carolina Urologic Research Center is involved with conducting 158 clinical trials across 99 conditions. There are 3 research doctors associated with this hospital, such as Neal Shore, Abhishek Srivastava, MD, and Robert Jansen, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.